- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07321431
The Optimal Measurement Time for the New Gallbladder Function Assessment Method
January 6, 2026 updated by: Wenbo Meng, Hepatopancreatobiliary Surgery Institute of Gansu Province
The Optimal Measurement Time for the New Gallbladder Function Assessment Method: A Prospective, Multicenter, Double-Blind, Crossover Trial
This is a multicenter, prospective, randomized, double-blind, crossover study involving healthy individuals, aiming to evaluate the stability of oral protein bars + olive oil as a new method for determining gallbladder contraction function and its optimal diagnostic time window.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This is a multicenter, prospective, randomized, single-blind, crossover study involving healthy individuals.
This study will use a crossover trial method to compare oral fried eggs with oral protein bars + olive oil.
Gallbladder ultrasound examinations will be performed at different time points to measure gallbladder volume, and the changes in gallbladder contraction rates at different time points under the two interventions will be calculated to determine the optimal time window for assessing gallbladder contraction function.
On the other hand, the investigators will verify the stability of oral protein bars plus olive oil as a new method for measuring gallbladder contraction function, evaluate its reliability and reproducibility across different regions, hospitals, and populations, ensure its wide clinical application, and provide stronger support for the diagnosis and treatment of gallbladder-related diseases.
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Long Deng, M.D.
- Phone Number: 13893192432
- Email: ldyy_longdengld@lzu.edu.cn
Study Contact Backup
- Name: Wenbo Meng, M.D. Ph. D.
- Phone Number: 13919177177
- Email: mengwb@lzu.edu.cn
Study Locations
-
-
Gansu
-
Lanzhou, Gansu, China, 730000
- Recruiting
- Hepatopancreatobiliary Surgery Institute of Gansu Province
-
Contact:
- Wenbo Meng, MD,PhD
- Phone Number: +8613919177177
- Email: mengwb@lzu.edu.cn
-
-
Hebei
-
Qinhuangdao, Hebei, China, 066000
- Recruiting
- The First Hospital of Qinhuangdao
-
Contact:
- Di Wu, M. D.
- Phone Number: +8615232304212
- Email: woody19840818@163.com
-
-
Liaoning
-
Shenyang, Liaoning, China, 110016
- Recruiting
- The Jinqiu Hospital of Liaoning Province
-
Contact:
- Hao Xin, M. D.
- Phone Number: +8617740079110
- Email: 526375164@163.com
-
-
Ningxia
-
Yinchuan, Ningxia, China, 750011
- Recruiting
- People's Hospital of Ningxia Hui Autonomous Region
-
Contact:
- Rui Wang, M. D.
- Phone Number: +8619995350582
- Email: 19995350582@163.com
-
-
Shanxi
-
Xi’an, Shanxi, China, 710054
- Recruiting
- Honghui Hospital of Xi'an Jiaotong University
-
Contact:
- Yuanyuan Sun, M. D.
- Phone Number: +8615991695737
- Email: 415315217@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Ultrasound assessment identifies people with normal biliary tract structure.
Exclusion Criteria:
- History of Endoscopic Retrograde Cholangiopancreatography
- Previous gallstone removal surgery with gallbladder preservation
- Other biliary tract diseases and related surgical history
- History of acute or chronic pancreatitis
- History of gastrointestinal surgery
- Gastrointestinal obstruction
- Dysfunction of the sphincter of Oddi
- Gallbladder neck polyps
- Abnormal gallbladder structure
- Gallbladder mass
- Biliary infection or stones
- Congenital biliary abnormalities
- Biliary injury or surgery
- Biliary tumors
- Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
- Significant arrhythmia, bradycardia, or atrioventricular block
- Severe hypertension, liver or kidney insufficiency
- Immune, endocrine, hematological, or mental disorders
- Severe cerebrovascular disease
- Allergy to relevant foods
- Pregnant or breastfeeding women
- Unwillingness or inability to consent to participation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: fried eggs
First, the intervention of oral administration of 2 fried eggs is carried out.
The size of the gallbladder is evaluated by ultrasound examination.
The washout period is 1 week.
After that, the first intervention process of group B is repeated.
|
First, the intervention of oral administration of 2 fried eggs is carried out.
The size of the gallbladder is evaluated by ultrasound examination.
The washout period is 1 week.
After that, the first intervention process of group B is repeated.
|
|
Active Comparator: protein bars
First, an intervention with oral protein bars + 50ml olive oil is conducted.
The size of the gallbladder is evaluated through ultrasound examination.
The washout period is 1 week.
After that, the first intervention process of Group A is repeated.
|
First, an intervention with oral protein bars + 50ml olive oil is conducted.
The size of the gallbladder is evaluated through ultrasound examination.
The washout period is 1 week.
After that, the first intervention process of Group A is repeated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gallbladder Volume
Time Frame: during procedure
|
Formula for Ultrasound Measurement of Gallbladder Volume (L × W × D × 0.52).
Measurements were taken every 20 minutes starting from 30 minutes after the intervention, with a total of 5 measurements (i.e., the gallbladder volume was measured at 30 minutes, 50 minutes, 70 minutes, 90 minutes, and 110 minutes respectively).
|
during procedure
|
|
Gallbladder contraction rate
Time Frame: during procedure
|
Subtract the volume of the gallbladder after intervention from the volume of the gallbladder on an empty stomach, then divide by the volume of the gallbladder on an empty stomach, and finally multiply by A-B/A%.
The gallbladder contraction rate was calculated at all the above time points.
|
during procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of Abdominal
Time Frame: 30 days
|
Pain Post-Intervention If abdominal pain is present, it will be assessed using the Numerical Rating Scale (NRS) within 0-10, The higher the score, the more serious it is.
|
30 days
|
|
Occurrence of Acute Pancreatitis
Time Frame: 30 days
|
Post-Intervention Pain and Amy 3 times as normal.
|
30 days
|
|
Occurrence of Gastrointestinal Bleeding Post-Intervention
Time Frame: 30 days
|
Black stool or decrease of hemoglobin.
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wenbo Meng, M.D. Ph. D., Hepatopancreatobiliary Surgery Institute of Gansu Province
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ai XN, Wang TF, Zhang Q, Ouyang CG, Wu ZY. Changes in Gallbladder Contractile Function and its Influencing Factors After Minimally Invasive Gallbladder-Preserving Surgery for Cholecystitis With Incarcerated Gallstones. Front Surg. 2022 Jul 14;9:926141. doi: 10.3389/fsurg.2022.926141. eCollection 2022.
- Rehfeld JF. Clinical endocrinology and metabolism. Cholecystokinin. Best Pract Res Clin Endocrinol Metab. 2004 Dec;18(4):569-86. doi: 10.1016/j.beem.2004.07.002.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 7, 2026
Primary Completion (Estimated)
December 20, 2026
Study Completion (Estimated)
December 20, 2026
Study Registration Dates
First Submitted
December 13, 2025
First Submitted That Met QC Criteria
December 28, 2025
First Posted (Estimated)
January 7, 2026
Study Record Updates
Last Update Posted (Actual)
January 8, 2026
Last Update Submitted That Met QC Criteria
January 6, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GB evaluating
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gallbladder; Functional Disturbance
-
Hepatopancreatobiliary Surgery Institute of Gansu...CompletedGallbladder; Functional DisturbanceChina
-
Loma Linda UniversityTerminatedHeart; Functional DisturbanceUnited States
-
Guangdong Provincial People's HospitalUnknownKidney; Functional DisturbanceChina
-
AstraZenecaCompletedHepatic; Functional DisturbanceUnited States
-
Cairo UniversityNot yet recruitingTemporomandibular; Functional DisturbanceEgypt
-
Far Eastern Memorial HospitalCompletedHeart; Functional DisturbanceTaiwan
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingAging | Functional Disturbance | Home
-
University of CopenhagenRigshospitalet, Denmark; Glostrup University Hospital, Copenhagen; Agroscope... and other collaboratorsTerminatedHealthy | Ileostomy; Functional DisturbanceDenmark
-
Szeged UniversityActive, not recruitingSurgery | Functional Disturbance | Dopamine | Bronchodilation | HeartHungary
-
University of Sao PauloSamsung ElectronicsCompletedHeart; Surgery, Heart, Functional Disturbance as ResultBrazil
Clinical Trials on oral administration of 2 fried eggs
-
University of ConnecticutCompleted
-
Medicines for Malaria VentureRichmond Pharmacology LimitedCompleted
-
Atridia Pty Ltd.Completed
-
Academy of Nutrition and DieteticsWuqu' Kawoq, Maya Health Alliance; Think Healthy Group, Inc.CompletedGrowth | Development; DelayedGuatemala
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Milton S. Hershey Medical CenterCompleted
-
Yonsei UniversityCompletedType 2 Diabetes | Non-alcoholic Fatty Liver DiseaseKorea, Republic of
-
Jianning YaoRecruiting
-
Shenzhen People's HospitalCompletedMicrobial Colonization | Skin Barrier to Water LossChina
-
Shenzhen People's HospitalNot yet recruitingMicrobial Colonization | Skin Barrier to Water Loss